Photo from wikipedia
Key Points • DTI is strongly associated with adverse clinical factors and inferior survival outcomes in patients with newly diagnosed MCL.• DTI should be reported in all patients newly diagnosed… Click to show full abstract
Key Points • DTI is strongly associated with adverse clinical factors and inferior survival outcomes in patients with newly diagnosed MCL.• DTI should be reported in all patients newly diagnosed with MCL enrolling in clinical trials; steps must be taken to avoid selection bias.
Keywords:
patients newly;
diagnosis treatment;
impact diagnosis;
newly diagnosed;
interval patients;
treatment interval
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!